Annals
Established in 1927 by the American College of Physicians
:
Advanced search
box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Tse, C.S. T.
space
  arrow  Abdullah, R.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

LETTER

Dissolving Phenytoin Precipitate in Central Venous Access Device

right arrow C.S. Ted Tse, PharmD, MBA, and Raied Abdullah, MD

15 June 1998 | Volume 128 Issue 12 Part 1 | Page 1049


TO THE EDITOR:

We describe a patient in whom sodium bicarbonate solution was used to restore patency of a central venous access device that was occluded by precipitate of phenytoin sodium injection. A 63-year-old man was admitted to our hospital for ventilator management complicated by distal esophagitis, deep venous thromboses requiring an inferior vena caval filter, recurrent aspiration pneumonia, line infections, respiratory failure requiring intubation, and seizures. A Groshong catheter (Bard Access Systems, Salt Lake City, Utah) was in the right subclavian vein. The patient had received antibiotics and vasopressor agents. At the time of the incident, medications were phenytoin by intravenous injection, 125 mg every 8 hours; norepinephrine by infusion, 8 mg in 250 mL of 5% dextrose in water; dopamine by infusion, 800 mg in 250 mL of 5% dextrose in water; vancomycin by injection, 1 g in 250 mL of normal saline every 36 hours; furosemide by injection, 20 mg every 8 hours; and total parenteral nutrition by continuous infusion.

After 30 doses of phenytoin sodium (USP, 250 mg/5 mL, Elkins-Sinn, Inc., Cherry Hill, New Jersey), the right subclavian Groshong port was found to be occluded. Urokinase, 5000 U (Abbokinase Open-Cath, Abbott Laboratories, Abbott Park, Illinois), was unsuccessfully given by injection to restore patency. The instillation of two 5-mL injections of sodium bicarbonate (8.4% sodium bicarbonate injection, USP, Abbott Laboratories) to the central line at 30-minute intervals resulted in good blood return in the line.

Injected phenytoin sodium crystallizes into insoluble phenytoin when admixed with solutions of 5% dextrose in water. A key factor in the precipitation of phenytoin is the pH of the solution. A solution of 5% dextrose in water, which is acidic (pH, 4.0), caused the phenytoin sodium injection, a basic solution (pH, 12.0), to precipitate. Instillation of sodium bicarbonate solution into the central line restored the pH to basic, with subsequent dissolution of the precipitate. Occlusion of the central line is common, and phenytoin precipitation may be overlooked as a source of occlusion. Admixing phenytoin sodium in 100 mL of normal saline and infusing it over 30 minutes may minimize the chance of precipitation. Only one report of a similar incident was found [1].

Injected sodium bicarbonate can clear phenytoin precipitate in central venous catheters. A syringe smaller than 5 mL should be avoided because it may generate high pressure and dislodge blood clots or phenytoin precipitate into the bloodstream. Clinical trials are needed to establish standardized procedures.


Author and Article Information
space
up arrowTop
dotAuthor & Article Info
down arrowReferences

Vencor Hospital-Northlake; Northlake, IL 60164


References
space
up arrowTop
up arrowAuthor & Article Info
dotReferences

1. Akinwande KI, Keehn DM. Dissolution of phenytoin precipitate with sodium bicarbonate in an occluded central venous device. Ann Pharmacother. 1995; 29:707-9.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.





box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Tse, C.S. T.
space
  arrow  Abdullah, R.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online